As you get used to the medication and gastrointestinal side effects ease, slowly work in a few of your favorite foods that youve been missing, especially the more flavorful ones, not necessarily high-fat or high-sugar foods
Research article safety and tolerability of sitagliptin in clinical studies: A pooled analysis of data from 10,246 patients with type 2 diabetes
NICE NG28 advises considering a GLP-1 receptor agonist in preference to a sulphonylurea when weight loss or avoidance of hypoglycaemia is a priority, though sulphonylureas remain appropriate options in selected patients
For patients with binge eating disorder, GLP-1 medications may actually be beneficial, as the appetite suppression can help reduce binge episodes
What This Means for Practice In day-to-day practice, clinicians should discuss the potential mood-related effects of GLP1 drugs with realistic expectations
Moreover, serotonin-induced hypoglycemia in mice was blocked by the nonspecific serotonin receptor antagonist cyproheptadine and the specific serotonin receptor 2 antagonist ketanserin.CONCLUSION Together these data suggest that increased postprandial serotonin may contribute to the pathophysiology of PBH and provide a potential therapeutic target.FUNDING National Institutes of Health (NIH) grant R01-DK121995, NIH grant P30-DK036836 (Diabetes Research Center grant, Joslin Diabetes Center), and Fundao de Amparo Pesquisa do Estado de So Paulo grant 2018/22111-2
